Cosmo Pharmaceuticals NV Stock Chart

Cosmo Pharmaceuticals NV (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Cosmo Pharmaceuticals NV

LSE
Market Cap
$1.14B
P/E Ratio
21.84
Shares Out.
16.84M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.

www.cosmopharma.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0RGI.GB (0RGI.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart